Laura Ortega Morán

5PUBLICATIONS
37CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 26, 2026
Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study.

Mariano Ponz-Sarvisé, Sun Young Rha, Carlos A Gomez-Roca

|Aug 07, 2024
SEOM clinical guidelines on venous thromboembolism (VTE) and cancer (2023).

Laura Ortega Morán, Francisco José Pelegrín Mateo, Rut Porta Balanyà

|Aug 21, 2023
Cost-effectiveness of apixaban and rivaroxaban in thromboprophylaxis of cancer patients treated with chemotherapy in Spain.

Andrés J Muñoz, Laura Ortega, Ana Gutiérrez

|Feb 02, 2023
A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective Cohorts.

Andrés Muñoz, Cihan Ay, Ella Grilz

|Apr 10, 2020
Incidence of venous thromboembolism in patients with colorectal cancer according to oncogenic status.

L Ortega Morán, P García Alfonso, I Aguilar Caballero

Pageof 1

Frequent Collaborators

3 joint publications

Andrés Muñoz

2 joint publications

Jose Manuel Soria

1 joint publications

Carme Font

1 joint publications

Julia Calzas